CDKN2D (cyclin dependent kinase inhibitor 2D)

2003-02-01  

Identity

HGNC
LOCATION
19p13.2
LOCUSID
ALIAS
INK4D,p19,p19-INK4D
FUSION GENES

Other Information

Locus ID:

NCBI: 1032
MIM: 600927
HGNC: 1790
Ensembl: ENSG00000129355

Variants:

dbSNP: 1032
ClinVar: 1032
TCGA: ENSG00000129355
COSMIC: CDKN2D

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000129355ENST00000335766P55273
ENSG00000129355ENST00000335766A0A024R796
ENSG00000129355ENST00000393599P55273
ENSG00000129355ENST00000393599A0A024R796

Expression (GTEx)

0
50
100
150
200
250

Pathways

PathwaySourceExternal ID
Cell cycleKEGGko04110
Cell cycleKEGGhsa04110
FoxO signaling pathwayKEGGhsa04068
Cell CycleREACTOMER-HSA-1640170
Cell Cycle, MitoticREACTOMER-HSA-69278
Mitotic G1-G1/S phasesREACTOMER-HSA-453279
G1 PhaseREACTOMER-HSA-69236
Cyclin D associated events in G1REACTOMER-HSA-69231
Cellular responses to stressREACTOMER-HSA-2262752
Cellular SenescenceREACTOMER-HSA-2559583
Oncogene Induced SenescenceREACTOMER-HSA-2559585
Oxidative Stress Induced SenescenceREACTOMER-HSA-2559580
Senescence-Associated Secretory Phenotype (SASP)REACTOMER-HSA-2559582

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
383788432024Deregulation of the p19/CDK4/CDK6 axis in Jak2(V617F) megakaryocytes accelerates the development of myelofibrosis.0
383788432024Deregulation of the p19/CDK4/CDK6 axis in Jak2(V617F) megakaryocytes accelerates the development of myelofibrosis.0
362926302022Identification of Cdk8 and Cdkn2d as New Prame-Target Genes in 2C-like Embryonic Stem Cells.1
362926302022Identification of Cdk8 and Cdkn2d as New Prame-Target Genes in 2C-like Embryonic Stem Cells.1
314002652020p19INK4d: More than Just a Cyclin-Dependent Kinase Inhibitor.4
327112192020p19(INK4d) inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia.0
314002652020p19INK4d: More than Just a Cyclin-Dependent Kinase Inhibitor.4
327112192020p19(INK4d) inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia.0
308081422019[The expression of P19ink4d in the pathogenesis and development of hearing loss].0
308081422019[The expression of P19ink4d in the pathogenesis and development of hearing loss].0
278792592017Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.15
289336662017Regulation of proliferation in developing human tooth germs by MSX homeodomain proteins and cyclin-dependent kinase inhibitor p19(INK4d).9
278792592017Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.15
289336662017Regulation of proliferation in developing human tooth germs by MSX homeodomain proteins and cyclin-dependent kinase inhibitor p19(INK4d).9
277636442016miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19(INK4D).4

Citation

Dessen P

CDKN2D (cyclin dependent kinase inhibitor 2D)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40038/cdkn2d-(cyclin-dependent-kinase-inhibitor-2d)